Board of Directors
The Board of Directors is the ultimate governing authority of the Foundation. Its mission is to govern the Foundation, protect the organization's image and assets, and be the moral voice of the Sarnoff community.
The Articles of Incorporation and Bylaws of the Foundation require that a majority of seats on its Board of Directors shall be persons nominated by the Foundation's designated medical institutions ("Publicly Supported Organizations," defined in the Internal Revenue Code). Dr. Sarnoff's successor nominates candidates for the remaining positions on the Board. Elected members who were nominated by the PSOs shall always constitute a majority of the Board. Director vacancies are filled on an annual basis; the Directors serve staggered terms. The present Board consists of eleven voting members. The Executive Director serves as a non-voting member. Mrs. Stanley J. Sarnoff is a non-voting honorary member of the Board.
The Sarnoff Cardiovascular Research Foundation is pleased to announce that Northwestern University and the University of Washington have accepted their appointment as nominating institutions of the Foundation. The Board of Directors of the Foundation, a 501(c)(3) public charity, is required to be controlled by Directors who are nominated to the Board by Publicly Supported Organizations (PSOs), as that term is defined in the Internal Revenue Code. PSOs must be actively engaged in developing, encouraging and maintaining a cardiovascular science program in the United States. Northwestern and Washington join five other nominating PSOs of the Foundation: Columbia University, Duke University, Johns Hopkins University, Mount Sinai Medical Center and University of Texas Southwestern Medical Center. These seven PSOs are thus entitled to nominate candidates for election to the Board of Directors. The Permanent Successor to Dr. Stanley J. Sarnoff nominates the remaining candidates for election to the Board of Directors.
 |
Ann Marie Schmidt, M.D.
Chair
|
Iven Young Professor of Endocrinology
New York University Langone Medical Centger
View biography |
 |
Charles Lowenstein, M.D. Immediate Past Chair |
Chief, Division of Cardiology, Department of Medicine
University of Rochester
View biography |
 |
Debra Schwinn, MD
Vice Chair
|
Professor and Chair of Anesthesiology University of Washington
View biography |
 |
Jon Lomasney, M.D. Treasurer |
Associate Professor, Department of Pathology and Department of Molecular Pharmacology and Biological Chemistry
Northwestern University School of Medicine
View biography |
 |
Ivor Benjamin, M.D. Secretary |
Chief of Cardiology
University of Utah Health Sciences Center
|
 |
Michael Cain, M.D. |
Dean, School of Medicine and Biomedical Sciences
University at Buffalo
View biography |
 |
Anne Curtis, M.D. |
Charles and Mary Bauer Professor of Medicine
Chair, Department of Medicine
University at Buffalo
View biography |
 |
David Kandzari, M.D. |
Director, Interventional Cardiology Research Piedmont Heart Institute LaJolla, CA
View biography |
 |
Clay Marsh, M.D.
|
Professor of Medicine
The Ohio State University Medical Center
View biography |
 |
Andrew Plump, M.D., Ph.D.
|
Vice President and Worldwide Discovery Head for Cardiovascular Diseases
Merck & Co., Inc.
|
 |
Anne Taylor, M.D. |
Vice Dean for Academic Affairs
Columbia University Medical Center
College of Physicians and Surgeons
View biography |
 |
Philip Tsao, Ph.D.
|
Associate Professor of Medicine
Stanford University School of Medicine |
 |
Myron Weisfeldt, M.D. |
Chairman of the Department of Medicine
Johns Hopkins Medical Institutions
View biography |
 |
Anita Ying, M.D.
|
Assistant Professor Department of Endocrine Neoplasia and Hormonal Disorders The University of Texas MD Anderson Cancer Center |
|
|